U.S. pharma giant copyright scrapped two experimental weight loss pills final 12 months—a once-everyday tablet, lotiglipron, on account of elevated liver enzymes and a two times-day-to-day capsule, danuglipron, as a consequence of sturdy Uncomfortable side effects—but CEO Albert Bourla has mentioned the company is determined to “Participate i